Class 23 review Flashcards

1
Q

Asthma

A

Asthma is a chronic inflammatory disorder of the airways. When the airways become inflamed, some obstruction of airflow occurs and we will see symptoms like breathlessness, coughing, wheezing, chest tightness. The airways become hyper-responsive to certain triggers that can bring on an asthma attack.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Diagnosis of asthma

A

spirometry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

exacerbation

A

When a person with COPD has a sudden increase in symptoms. Symptoms are worse for a period of time and then may improve. Exacerbations are often precipitated by respiratory illness such as colds, pneumonia and influenza. Exacerbations of COPD are frequently the cause of hospitalization. Dyspnea, cough, sputum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Asthma triggers

A

Allergens
Exercise
Respiratory infection
Nose & sinus problem
Drugs (NSAIDS, beta blockers)
GERD
Air pollutants
Emotional stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Early phase response of asthma

A

Bronchospasm. Increased mucus secretion, edema formation, and increased amounts of sputum
30-60 min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Late phase response of asthma

A

Primarily inflammation
Peaks 5-12 hrs
Corticosteroids are effective in preventing and reversing this cycle
If not treated, may lead to irreversible lung damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Asthma clinical picture

A

Obstruction & air trapping
Dyspnea & chest tightness
Speech 1-2 words
Anxiety, distress
Tachycardia
Initially low O2 low CO2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

SABAs - Inhaled

A

B-Adrenergic agonists

  • prevent release of inflammatory mediators from mast cells
  • SABAs not for ongoing long-term use
  • onset of action in minutes and duration of 4-8 hr
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

SABAs example

A

Salbutamol (Ventolin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

LABAs - Inhaled

A
  • long-acting: take q12h
  • used for long-term control asthma
  • control - not a rescue inhaler
  • works by same mechanisms as SABAs
  • can be combined with inhaled corticosteroid (ICS) (fluticasone)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

LABAs example

A

Salmeterol (Serevent diskus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Anticholinergic - Inhaled

A
  • block action of acetylcholine
  • usually used in combination with another bronchodilator
  • most common adverse effect is dry mouth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Anticholinergic example

A

Ipratropium (Atrovent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Methylxanthines

A
  • less effective long-term bronchodilator
  • controller after trying ICS, LABA, and LTRAs
  • Narrow toxic/ therapeutic ratio and frequent adverse events
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Methylxanthines example

A

Theophylline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Corticosteroids

A
  • decreases inflammation in airways by suppressing immune response
  • reduce bronchial hyper-responsiveness
  • decreases mucus production
  • are taken on a fixed schedule
  • oropharyngeal candidiasis, hoarseness, and a dry cough are local adverse effects of inhaled drug
  • adverse effects can be reduced by a spacer or gargling after use
  • taken daily, not a rescue drug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Corticosteroids examples

A

Inhaled: fluticasone (Flovent)
Systemic: prednisone

18
Q

Leukotriene modifiers or inhibitors

A
  • block action of leukotrienes - which are potent bronchoconstrictors
  • have both bronchodilator and anti-inflammatory effects
  • not indicated for acute attacks
  • used prophylactic and maintenance therapy
  • taken daily not a rescue drug
19
Q

Leukotriene modifiers or inhibitors example

A

montelukast (Singulair)

20
Q

Mast cell stabilizers

A
  • alternative to corticosteroids if needed
  • inhibits release of histamine from mast cells to reduce inflammation
  • may cause local irritation in nose, mouth, throat
  • taken daily not a rescue drug
21
Q

Mast cell stabilizers example

A

Cromolyn

22
Q

COPD

A

Chronic obstructive pulmonary disease

  • disease caused by smoking 80-90%
  • progressive partially reversible airflow obstruction
  • increasing frequency & severity of exacerbations
  • characterized by chronic inflammation found in the airways, lung parenchyma, and pulmonary blood vessels
23
Q

COPD risk factors

A

Cigarette smoking
Occupational chemicals and dust
Air pollution
Infection
Heredity
Aging

24
Q

COPD and smoking

A
  • COPD ~ age 50 or ~20 pack years
  • 15% of smokers develop clinically significant airway obstruction
  • 80% to 90% of COPD deaths are related to tobacco smoking
25
Q

Emphysema

A

Destruction of alveoli and permanent enlargement of airways without fibrosis

26
Q

Chronic bronchitis

A

Over-secretion mucous and chronic productive cough that lasts more than 3 months for a minimum 2 years in a row

27
Q

COPD pathophysiology

A

Air is trapped inside the lungs which causes hyperinflation and overexpansion
Mucus hyper secretion
Airflow limitation
Loss of elastic recoil
Pulmonary hypertension

28
Q

COPD clinical manifestations

A

Underweight with adequate caloric intake
Anorexia
Chronic fatigue
Bluish-red colour of skin
- polycythemia and cyanosis
Prolonged expiratory phase
Wheezes
Decreased breath sounds
Barrel chest

29
Q
A
30
Q

Cor Pulmonale pathophysiology

A

Hypertrophy of right side of heart

  • Result of pulmonary hypertension
  • Late manifestation of chronic pulmonary heart disease
  • Eventually causes right-sided heart failure
31
Q

Cor Pulmonale symptoms

A

Dyspnea

Distended neck veins

Hepatomegaly with rihgt upper quadrant tenderness

Peripheral edema

Weight gain

Ascites

Epigastric distress

32
Q

Salbutamol (Ventolin)

A

Short acting: 3-5 hourss

Activate beta 2 adrenergic receptors in the pulmonary smooth muscle, causing bronchodilation.

Also may suppress histamine release

33
Q

Salmeterol (Serevent diskus)

A

Long-acting: 12 hours

Used for long-term control of chronic COPD.

Works by same mechanism as SABAs

34
Q

Ipratropium(Atrovent)

A

Short-acting muscarinic antagonist (6 hours)

Blocks muscarinic receptors in the bronchi, which decreases and prevents further bronchoconstriction

35
Q

Tiotropium (Spiriva)

A

Long-acting muscarinic receptor (24 hours).

Works in the same mechanism as Ipratropium but is more effective

36
Q

ICS Fluticasone (Flovent) or Beclomethasone

A

Decreases inflammation in airways by suppressing immune response.

Not to be used alone in COPD, used with a LABA.

37
Q

Asthma diagnosis

A

test for reactivity

Methacholine Challenge (histamine)

Exercise Challenge

Drop by 15 – 20% of FEV1 indicates hyper-responsive airways

  • Allergy testing
  • Sputum eosinophils
  • Sputum culture and sensitivity
38
Q

COPD diagnosis

A

test for obstruction

Reduced FEV1/FVC ratio

Increased residual volume COPD is diagnosed when FEV1/FVC is less than 70% predicted

  • Walk test (6 min.) to determine O2 desaturation in the blood with exercise
  • ECG can show signs of right ventricular failure
39
Q

Carbon dioxide Narcosis

A

a tolerance for high levels of carbon dioxide and development of a “hypoxic drive” to breath

Monitor: cognitive changes and physical assessment

40
Q

Oxygen Toxicity

A

high concentrations of oxygen can damage alveolar-capillary membranes

41
Q

Absorption Atelectasis

A

high oxygen washes out nitrogen from alveoli → alveolar collapse